By Pooja Toshniwal PahariaReviewed by Danielle Ellis, B.Sc.Jun 26 2024 In a recent study published in JID Innovations, researchers assessed health communication messages that effectively educate the public and raise intentions to get skin exams.
About the study In the present study, researchers sought to uncover health communication techniques that improve correct visual identification of moles, understanding of melanoma cautioning indicators, dermatological self-check intentions, and positive attitudes regarding examining their skin. In four experimental settings, participants read six control-type messages or the ones that increase knowledge, self-efficacy, or both. Awareness messages aimed to enhance melanoma cautionary sign awareness and mole identification accuracy, and self-efficacy texts aimed to boost the viewer's confidence in skin monitoring to prevent melanoma. Self-efficacy messaging included parallel comparisons of the identical body shot but with one photo featuring an easily identifiable melanoma.
Results The study included 401 individuals with a mean age of 40 years, among whom 46% were female. The reading of messages aimed to enhance melanoma knowledge led to participants correctly identifying a higher proportion of moles with higher awareness of melanoma cautionary signs than individuals with only self-efficacy-type or control message exposure, indicating their enhanced ability to distinguish between melanomas and benign moles.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers discover new therapeutic target for the treatment of melanoma resistant to targeted therapiesAn international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies. Inhibition of the VARS enzyme could prevent this therapeutic resistance by resensitizing tumors resistant to these targeted therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »
Researchers use AI, social media to identify health concerns of people living with HIV and AIDSMachine learning, artificial intelligence (AI) and social media are providing researchers with the opportunity to analyze valuable information about social issues in relation to health and mental health, particularly in relation to topics people may be reluctant to discuss in other settings, according to Richard Lomotey, associate professor of...
Source: medical_xpress - 🏆 101. / 51 Read more »
Nonsignificant survival benefit seen for dabrafenib, trametinib in melanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published in the New England Journal of Medicine.
Source: medical_xpress - 🏆 101. / 51 Read more »
New Approach to Treating MelanomaAn international research team, led by Professor Wenbo Bu of Fudan University and Distinguished Professor Dayong Jin of the University of Technology Sydney, have discovered an innovative method to effectively treat cancer by reactivating suppressed metabolic pathways in cancer cells.
Source: NewsMedical - 🏆 19. / 71 Read more »
Study reveals new mechanism of drug resistance in melanoma leptomeningeal diseaseLeptomeningeal disease is a rare but lethal complication faced by late-stage melanoma patients. It occurs when cancer cells spread to the membranes covering the brain and spinal cord, or the leptomeninges. This condition, which affects 5% to 8% of melanoma patients, often leads to rapid deterioration and is notoriously resistant to therapies.
Source: medical_xpress - 🏆 101. / 51 Read more »